尼秦类新精神活性物质及其检验方法研究进展

doi:10.3969/j.issn.1671-2072.2024.04.003

摘要/Abstract

摘要： 新精神活性物质作为继传统毒品和合成毒品后的第三代毒品，在全球范围内的滥用愈发严重，已成为世界各国重点关注的突出问题。合成阿片类物质作为其中潜在危害最大的物质，其滥用种类不断增长，严重威胁人类健康和公共安全。尼秦类物质作为一类新型阿片类毒品，在全球范围内的制造、走私和滥用问题越来越突出。从尼秦类物质的基本结构、滥用和管制情况及其药理和毒理学性质、代谢情况、检测方法四个方面展开综述，对尼秦类物质的检测技术发展等方面进行简要展望，以期为尼秦类物质的深入研究提供思路。

关键词: 新精神活性物质, 尼秦类物质, 药理和毒理学, 代谢, 检验方法

Abstract: New psychoactive substances (NPS), as the third generation of drugs after traditional drugs and synthetic drugs, are being abused globally, and have become a prominent issue of priority concern for countries around the world. Novel synthetic opioids are one of the most potentially harmful substances and have been abused increasingly, posing a serious threat to human health and public safety. As one class of novel synthetic opioids, the problem of manufacturing, smuggling and abuse of Nitazenes are becoming more and more seriously all over the world. In this paper, the basic structure, abuse and control, pharmacological and toxicological properties, metabolism and detection methods of Nitazenes were reviewed. Moreover, the development of detection technology of Nitazenes were briefly prospected, in order to provide reference for further study of Nitazenes.

Key words: new psychoactive substance (NPS), Nitazene, pharmacology and toxicology, metabolism, testing method

中图分类号:

D918.8

沈瑞迪, 钱振华. 尼秦类新精神活性物质及其检验方法研究进展[J]. 中国司法鉴定, 2024(4): 21-28.

SHEN Ruidi, QIAN Zhenhua. Research Progress of Nitazenes New Psychoactive Substances and Their Testing Methods[J]. Chinese Journal of Forensic Sciences, 2024(4): 21-28.

参考文献

参考文献：
[ 1 ] UNODC. World drug report 2022[EB/OL]. [2023-02-20].https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html.
[ 2 ] WALTON S E，KROTULSKI A J，LOGAN B K. A forward-thinking approach to addressing the new synthetic opioid 2-benzylbenzimidazole nitazene analogs by liquid chromatography-tandem quadrupole mass spectrometry （LC-QQQ-MS）[J]. Journal of Analytical Toxicology，2022，46（3）： 221-231.
[ 3 ] European Monitoring Centre for Drugs and Drug Addiction.European drug report 2021： Trends and developments[M]. Brussels，Belgium：Publications Office of the European Union. 2021.
[ 4 ] HUNGER A，KEBRLE J，ROSSI A，et al. Synthese basisch substituierter，analgetisch wirksamer benzimidazol-derivate[J]. Experientia，1957，13： 400-401.
[ 5 ] HUNGER A，KEBRLE J，ROSSI A，et al. Benzi-midazol-derivate und verwandte heterocyclen. II. synthese von 1-aminoalkyl-2-benzyl-benzimidazolen[J]. Helvetica Chimica Acta，1960，43（3）： 800-809.
[ 6 ] HUNGER A，KEBRLE J，ROSSI A，et al. Benzimidazole-derivate und verwandte heterocyclen III. synthese von 1-aminoalkyl-2-benzyl-nitro-benzimidazolen[J].Helvetica Chimica Acta，1960，43（4）： 1032-1046.
[ 7 ] HUNGER A，KEBRLE J，ROSSI A，et al. Benzimidazol-derivate und verwandte heterocyclen. VI. synthese von phenyl-[1-aminoalkyl-benzimidazolyl-（2）]-essigsaurees-tern und-amiden[J]. Helvetica Chimica Acta，1960，43（6）： 1727-1733.
[ 8 ] SHULGIN A T. Drugs of abuse in the future[J]. Clinical Toxicology，1975，8（4）： 405-456.
[ 9 ] European Monitoring Centre for Drugs and Drug Addiction. (2020) Risk assessment report on the new psychoactive substance N,N diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro- 1H-benzimidazole-1-ethanamine (isotonitazene) in accordance with Article 5c of Regulation (EC) No. 1920/2006 (as amended)[EB/OL]. [2023-02-20].https://d9www.euda.europa.eu/publications/risk-assess-ments/isotonitazene_en.
[10] DrugsData.org. Test Details: Results #8739：Heroin 8739. 2020[EB/OL]. [2023-02-20]. https://www.drugsdata.org/view.php?id=8739.
[11] World Health Organization. Summary assessment and recommendations of the 43rd ECD[EB/OL].[2023-02-20].https：//www.who.int/docs/default-source/medicines/43ec-dd-unsg-annex1-to-letter-30nov20.pdf?sfvrsn=1cc00192_5.
[12] EMCDDA. EMCDDA initial report on the new psychoactive substance N，N-diethyl-2-[[4-（1-methylethoxy）phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine（isotonitazene）[EB/OL].[2023-02-20].https：//d9www.euda.europa.eu/publications/initial-reports/isotonitazene _en.
[13] MUELLER F，BOGDAL C，PFEIFFER B，et al. Isotonitazene： Fatal intoxication in three cases involving this unreported novel psychoactive substance in Switzerland[J]. Forensic Science International，2021，320：110686.
[14] POWER M. 40 A mericans are dying every month from taking this new，legal opioid. 2020[EB/OL].[2023-02-20].https：//www.vice.com/en/article/wxebjb/40-americans-are-dying-every-month-from-taking-this-new-legal-opioid/.
[15] NPS Discovery.Metonitazene monograph[EB/OL]. [2023-02-20].https：//www.cfsre.org/images/monographs/Meto-nitazene_073020_NMSLabs_Report.pdf.
[16] KROTULSKI A J，PAPSUN D M，WALTON S E，et al. Metonitazene in the United States—Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry[J]. Drug Testing and Analysis，2021，13（10）：1697-1711.
[17] NPS Discovery. Butonitazene monograph[EB/OL]. [2023-02-20].https：//www.cfsre.org/images/monographs/Butonitazene_011521_ToxicologyAnalyticalReport.pdf.
[18] NPS Discovery. Etodesnitazene monograph[EB/OL].[2023-02-20]. https：//www.cfsre.org/images/monographs/Etode-snitazene_022321_ToxicologyAnalyticalReport.pdf.
[19] NPS Discovery. Flunitazene monograph[EB/OL]. [2023-02-20].https：//www.cfsre.org/images/monographs/Flunitazene_032621_ToxicologyAnalyticalReport.pdf.
[20] NPS Discovery.（2021）Protonitazene monograph[EB/OL]. [2023-02-20].https： //www.cfsre.org/images/monographs/Protonitazene_052621_ToxicologyAnalyticalReport.pdf.
[21] NPS Discovery. N-Pyrrolidino-Etonitazene monograph[EB/OL].[2023-02-20]. https：// www.cfsre.org/images/monographs / N-Pyrrolidino_Etonitazene_051321_Toxi-cology AnalyticalReport.pdf.
[22] UNODC. The International Drug Control Conventions： Schedules of the Single Convention on Narcotic Drugs of 1961，as Amended by the 1972 Protocol.1975[EB/OL].[2023-02-20]. https：//www.unodc.org/documents/commissions / CND/Int_Drug_Control_Conventions / Ebook /
The_International_Drug_Control_Conventions_E.pdf.
[23] DE LUCA MA，TOCCO G，MOSTALLINO R，et al. Pharmacological characterization of novel synthetic opioids： Isotonitazene，metonitazene，and piperidylthiambutene as potent μ-opioid receptor agonists[J]. Neuropharmacology，2022，221：109263.
[24] VANDEPUTTE M M，VAN U K，LAYLE N K，et al. Synthesis，chemical characterization，and μ-opioid receptor activity assessment of the emerging group of “Nitazene” 2-benzylbenzimidazole synthetic opioids[J]. ACS Che-mical Neuroscience，2021，12： 1241-1251.
[25] VANDEPUTTE M M，KROTULSKI A J，WALTHER D，et al. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene （etonitazepyne），a newly emerging 2-benzyl-benzimidazole “nitazene” synthetic opioid[J]. Archives of Toxicology，2022，96（6）： 1845-1863.
[26] VANDEPUTTE M M，VEROUGSTRAETE N，WALT-HER D，et al. First identification，chemical analysis and pharmacological characterization of N-piperidinyl etonitazene （etonitazepipne），a recent addition to the 2-benzylbenzimidazole opioid subclass[J]. Archives of Toxicology，2022，96 （6）：1865-1880.
[27] ALEXANDER G，GONDIN A B，ANDREA K，et al. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists[J]. Science Signaling，2020，13（625）：3140.
[28] BROMIG G. Über neue starkwirkende Analgetika und ihre klinische Erprobung[J]. Journal of Molecular Medicine，1958，36： 960-963.
[29] ISTVÁN U，RACHEL C，MICHAEL E B，et al. DARK classics in chemical neuroscience： Etonitazene and related benzimidazoles[J]. ACS Chemical Neuroscience，2021，12（7）： 1072-1092.
[30] RONDEAU D B，TURCOTTE M，YOUNG L，et al. Similarities of the cataleptic state induced by β-endorphin and morphine[J]. Pharmacology Biochemistry and Behavior，1982，17（4）： 703-707.
[31] BURNS G，DERIENZ R T，BAKER D D，et al. Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?[J]. Clinical Toxicology，2016，54（5）： 420-423.
[32] KROTULSKI A J，PAPSUN D M，KACINKO S L，et al. Isotonitazene quantitation and metabolite discovery in authentic forensic casework[J]. Journal of Analytical Toxicology，2020，44（6）： 521-530.
[33] KIMANI M M，KERN S，LANZAROTTA A，et al. Rapid screening of 2-benzyl- benzimidazole nitazene analogs in suspect counterfeit tablets using Raman，SERS，DART-TD-MS，and FT-IR[J]. Drug Testing and Analysis，2023，15（5）： 539-550.
[34] BLANCKAERT P，CANNAERT A，VAN UYTFANGHE K，et al. Report on a novel emerging class of highly potent benzimidazole NPS opioids：Chemical and in vitro functional characterization of isotonitazene[J]. Drug Testing and Analysis，2020，12（4）： 422-430.
[35] SICZEK M，ZAWADZKI M，SICZEK M，et al. Etazene（N，N-diethyl-2-{[（4-ethoxyphenyl） methyl]-1H-ben-zimidazol-1-yl}-ethan-1-amine（dihydrochloride））： A novel benzimidazole opioid NPS identified in seized material： Crystal structure and spectroscopic characterization[J]. Forensic Toxicology，2021，39（1）： 146-155.
[36] BLANCKAERT P，BALCAEN M，CLINE VANHEE，et al. Analytical characterization of “etonitazepyne”，a new pyr-rolidinyl-containing 2-benzylbenzimidazole opioid sold online[J]. Drug Testing and Analysis， 2021，13（2）： 1-8.
[37] TATSUYUKI K，YUKI O，HIROKI S，et al. Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers[J]. Drug Testing and Analysis，2023，15（4）： 449-457.
[38] GRIGORYEV A，KAVANAGH P，DOWLING G，et al. Tentative identification of etazene （etodesnitazene） metabolites in rat serum and urine by gas chromatography-mass spectrometry and accurate mass liquid chroma-tography-mass spectrometry[J]. Journal of Analytical Toxicology，2022，46： 1032-1037.

[1]	王鑫, 陈航, 向平. 向毒而战 ——2023年国际法医毒物学家协会（TIAFT）第60届年会会议综述[J]. 中国司法鉴定, 2024, 0(1): 36-41.
[2]	武丽娜, 肖辅, 林佳曼, 李天乐, 向平, 施妍, 贠克明. 新精神活性物质定量构效关系方法研究及应用[J]. 中国司法鉴定, 2023, 0(1): 45-52.
[3]	郑嘉明, 王鑫, 赵云丽, 向平. 毛发中合成大麻素类新精神活性物质分析研究进展[J]. 中国司法鉴定, 2023, 0(1): 53-62.
[4]	陆佳玥, 严慧, 陈航, 沈敏. 我国法医毒物学领域新精神活性物质研究现状——基于文献计量学分析[J]. 中国司法鉴定, 2022, 0(6): 37-47.
[5]	任航, 赵云丽, 原帅, 向平, 沈保华. 基于污水流行病学的全球毒品流行趋势[J]. 中国司法鉴定, 2022, 0(5): 22-38.
[6]	翟文娅, 向平, 乔正, 党永辉, 施妍. 苯乙胺类新精神活性物质及其代谢研究进展[J]. 中国司法鉴定, 2022, 0(3): 24-35.
[7]	刘梦曦, 向平, 于治国, 等. 合成大麻素类新精神活性物质研究进展 [J]. 中国司法鉴定, 2021, 0(4): 30-40.
[8]	周莉英. 苯乙胺类新精神活性物质的研究进展[J]. 中国司法鉴定, 2020, 0(6): 17-27.
[9]	徐多麒. 论我国新精神活性物质监测评估系统完善[J]. 中国司法鉴定, 2020, 0(6): 60-65.
[10]	钱振华, 郑晓雨, 刘翠梅. 苯二氮卓类新精神活性物质去氯依替唑仑的定性检验方法研究[J]. 中国司法鉴定, 2020, 0(1): 49-53.
[11]	钱振华, 赵彦彪, 贾薇等. 新精神活性物质哌异丙基酯的识别与检验[J]. 中国司法鉴定, 2019, 0(5): 15-20.
[12]	王柔嘉, 向平, 于治国等. 色胺类新精神活性物质的研究进展[J]. 中国司法鉴定, 2019, 0(4): 43-55.
[13]	王璐莹, 倪春芳, 姜凤丽等. 大鼠尿液与血液中海洛因4种代谢物的检测时限研究[J]. 中国司法鉴定, 2019, 0(3): 14-21.
[14]	盛振海张玉荣袁晓亮何思阳连茹徐金伦孙文娟. 新精神活性物质“MAB-CHMINACA”的鉴定研究[J]. 中国司法鉴定, 2019, 0(2): 20-25.
[15]	徐秀明. 液相色谱-串联质谱法检测合成大麻素MAM-2201[J]. 中国司法鉴定, 2019, 0(1): 31-34.